Strategy Signal
Strategy Signal LLC is an independent equity research firm focused on the pharmaceutical, biotechnology and life sciences sectors.

Strategy Signal provides proprietary fundamental quantitative research to institutional investors that target substantial growth opportunities – – adding significant value while minimizing risk. A comprehensive understanding of the macro and competitive landscapes, the strategy-shifting product and manufacturing technologies, and the management of assets that will shape the pharma/biotech future are the foundations of the firm’s disciplined metric methodology.